nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—SLC28A3—Gemcitabine—urinary bladder cancer	0.332	1	CbGbCtD
Adenosine—Cytarabine—Gemcitabine—urinary bladder cancer	0.168	0.35	CrCrCtD
Adenosine—Azacitidine—Gemcitabine—urinary bladder cancer	0.159	0.333	CrCrCtD
Adenosine—Decitabine—Gemcitabine—urinary bladder cancer	0.152	0.317	CrCrCtD
Adenosine—SLC28A3—prostate gland—urinary bladder cancer	0.00424	0.0814	CbGeAlD
Adenosine—ADORA2B—prostate gland—urinary bladder cancer	0.00302	0.058	CbGeAlD
Adenosine—ADA—prostate gland—urinary bladder cancer	0.00277	0.053	CbGeAlD
Adenosine—ADK—prostate gland—urinary bladder cancer	0.00226	0.0433	CbGeAlD
Adenosine—DPP4—prostate gland—urinary bladder cancer	0.00219	0.042	CbGeAlD
Adenosine—ADORA2B—smooth muscle tissue—urinary bladder cancer	0.00214	0.041	CbGeAlD
Adenosine—ADORA2B—urethra—urinary bladder cancer	0.00202	0.0388	CbGeAlD
Adenosine—ADK—seminal vesicle—urinary bladder cancer	0.00191	0.0366	CbGeAlD
Adenosine—ADA—renal system—urinary bladder cancer	0.00189	0.0361	CbGeAlD
Adenosine—Cytarabine—POLB—urinary bladder cancer	0.00187	0.362	CrCbGaD
Adenosine—DPP4—seminal vesicle—urinary bladder cancer	0.00185	0.0355	CbGeAlD
Adenosine—DPP4—epithelium—urinary bladder cancer	0.00161	0.0309	CbGeAlD
Adenosine—ADK—smooth muscle tissue—urinary bladder cancer	0.0016	0.0307	CbGeAlD
Adenosine—DPP4—smooth muscle tissue—urinary bladder cancer	0.00155	0.0297	CbGeAlD
Adenosine—ADK—renal system—urinary bladder cancer	0.00154	0.0295	CbGeAlD
Adenosine—ADK—urethra—urinary bladder cancer	0.00151	0.029	CbGeAlD
Adenosine—ADA—female reproductive system—urinary bladder cancer	0.00151	0.0289	CbGeAlD
Adenosine—DPP4—renal system—urinary bladder cancer	0.00149	0.0286	CbGeAlD
Adenosine—ADORA2B—vagina—urinary bladder cancer	0.00149	0.0286	CbGeAlD
Adenosine—ADORA1—renal system—urinary bladder cancer	0.00148	0.0284	CbGeAlD
Adenosine—ADORA1—urethra—urinary bladder cancer	0.00145	0.0279	CbGeAlD
Adenosine—ADORA2A—female reproductive system—urinary bladder cancer	0.00137	0.0263	CbGeAlD
Adenosine—ADA—vagina—urinary bladder cancer	0.00137	0.0262	CbGeAlD
Adenosine—ADK—female reproductive system—urinary bladder cancer	0.00123	0.0236	CbGeAlD
Adenosine—DPP4—female reproductive system—urinary bladder cancer	0.0012	0.0229	CbGeAlD
Adenosine—Clofarabine—RRM2—urinary bladder cancer	0.00119	0.231	CrCbGaD
Adenosine—ADORA1—female reproductive system—urinary bladder cancer	0.00119	0.0227	CbGeAlD
Adenosine—ADK—vagina—urinary bladder cancer	0.00112	0.0214	CbGeAlD
Adenosine—DPP4—vagina—urinary bladder cancer	0.00108	0.0207	CbGeAlD
Adenosine—ADORA1—vagina—urinary bladder cancer	0.00107	0.0206	CbGeAlD
Adenosine—ADA—lymph node—urinary bladder cancer	0.000883	0.0169	CbGeAlD
Adenosine—ADK—lymph node—urinary bladder cancer	0.000722	0.0138	CbGeAlD
Adenosine—DPP4—lymph node—urinary bladder cancer	0.0007	0.0134	CbGeAlD
Adenosine—ADORA1—lymph node—urinary bladder cancer	0.000694	0.0133	CbGeAlD
Adenosine—Cladribine—RRM2—urinary bladder cancer	0.000686	0.133	CrCbGaD
Adenosine—Glucosamine—MMP9—urinary bladder cancer	0.000618	0.12	CrCbGaD
Adenosine—Glucosamine—TNF—urinary bladder cancer	0.000406	0.0786	CrCbGaD
Adenosine—Adenosine monophosphate—SRC—urinary bladder cancer	0.000392	0.0759	CrCbGaD
Adenosine—ADA—p73 transcription factor network—FAS—urinary bladder cancer	0.000351	0.00666	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.000334	0.00635	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000326	0.00619	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000326	0.00619	CbGpPWpGaD
Adenosine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—urinary bladder cancer	0.00032	0.00607	CbGpPWpGaD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000303	0.00577	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000301	0.00572	CbGpPWpGaD
Adenosine—DPP4—Peptide hormone metabolism—IGF1—urinary bladder cancer	0.000301	0.00571	CbGpPWpGaD
Adenosine—ADA—p73 transcription factor network—RB1—urinary bladder cancer	0.000268	0.0051	CbGpPWpGaD
Adenosine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN1A—urinary bladder cancer	0.000261	0.00496	CbGpPWpGaD
Adenosine—ADA—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000256	0.00487	CbGpPWpGaD
Adenosine—ADA—Validated transcriptional targets of TAp63 isoforms—EP300—urinary bladder cancer	0.000249	0.00472	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000245	0.00466	CbGpPWpGaD
Adenosine—Myocardial infarction—Etoposide—urinary bladder cancer	0.000227	0.00286	CcSEcCtD
Adenosine—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.000225	0.00284	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.000224	0.00427	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000224	0.00426	CbGpPWpGaD
Adenosine—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.000221	0.00278	CcSEcCtD
Adenosine—Cough—Thiotepa—urinary bladder cancer	0.000219	0.00277	CcSEcCtD
Adenosine—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.000219	0.00276	CcSEcCtD
Adenosine—Convulsion—Thiotepa—urinary bladder cancer	0.000218	0.00275	CcSEcCtD
Adenosine—Hypertension—Thiotepa—urinary bladder cancer	0.000217	0.00274	CcSEcCtD
Adenosine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000217	0.00274	CcSEcCtD
Adenosine—Ventricular tachycardia—Doxorubicin—urinary bladder cancer	0.000214	0.0027	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—CDX2—urinary bladder cancer	0.000214	0.00406	CbGpPWpGaD
Adenosine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000213	0.00269	CcSEcCtD
Adenosine—Anxiety—Thiotepa—urinary bladder cancer	0.000213	0.00269	CcSEcCtD
Adenosine—Injection site reaction—Doxorubicin—urinary bladder cancer	0.000213	0.00269	CcSEcCtD
Adenosine—Tinnitus—Cisplatin—urinary bladder cancer	0.000211	0.00266	CcSEcCtD
Adenosine—Flushing—Cisplatin—urinary bladder cancer	0.00021	0.00265	CcSEcCtD
Adenosine—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00021	0.00265	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—PTGS2—urinary bladder cancer	0.00021	0.00399	CbGpPWpGaD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—EP300—urinary bladder cancer	0.000207	0.00393	CbGpPWpGaD
Adenosine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.000206	0.0026	CcSEcCtD
Adenosine—ADK—Metabolism—GSTZ1—urinary bladder cancer	0.000206	0.00391	CbGpPWpGaD
Adenosine—Back pain—Gemcitabine—urinary bladder cancer	0.000205	0.00258	CcSEcCtD
Adenosine—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.000204	0.00257	CcSEcCtD
Adenosine—Arrhythmia—Cisplatin—urinary bladder cancer	0.000202	0.00255	CcSEcCtD
Adenosine—Tachycardia—Thiotepa—urinary bladder cancer	0.0002	0.00252	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.000196	0.00373	CbGpPWpGaD
Adenosine—Vision blurred—Fluorouracil—urinary bladder cancer	0.000196	0.00247	CcSEcCtD
Adenosine—ADK—Metabolism—GSTO2—urinary bladder cancer	0.000195	0.00371	CbGpPWpGaD
Adenosine—ADK—Metabolism—NAT1—urinary bladder cancer	0.000195	0.00371	CbGpPWpGaD
Adenosine—ADA—p73 transcription factor network—CDKN1A—urinary bladder cancer	0.000193	0.00366	CbGpPWpGaD
Adenosine—Cardiac disorder—Etoposide—urinary bladder cancer	0.000193	0.00243	CcSEcCtD
Adenosine—Flushing—Etoposide—urinary bladder cancer	0.000193	0.00243	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.00019	0.0036	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000187	0.00356	CbGpPWpGaD
Adenosine—Mediastinal disorder—Etoposide—urinary bladder cancer	0.000187	0.00236	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000187	0.00236	CcSEcCtD
Adenosine—Vision blurred—Cisplatin—urinary bladder cancer	0.000186	0.00234	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000185	0.00352	CbGpPWpGaD
Adenosine—Tremor—Cisplatin—urinary bladder cancer	0.000185	0.00233	CcSEcCtD
Adenosine—Cough—Gemcitabine—urinary bladder cancer	0.000185	0.00233	CcSEcCtD
Adenosine—Paraesthesia—Thiotepa—urinary bladder cancer	0.000184	0.00232	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—PTGS2—urinary bladder cancer	0.000184	0.00349	CbGpPWpGaD
Adenosine—ADA—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	0.000183	0.00349	CbGpPWpGaD
Adenosine—ADA—p73 transcription factor network—EP300—urinary bladder cancer	0.000183	0.00348	CbGpPWpGaD
Adenosine—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.000183	0.00231	CcSEcCtD
Adenosine—Hypertension—Gemcitabine—urinary bladder cancer	0.000183	0.0023	CcSEcCtD
Adenosine—Somnolence—Thiotepa—urinary bladder cancer	0.000182	0.0023	CcSEcCtD
Adenosine—Convulsion—Fluorouracil—urinary bladder cancer	0.00018	0.00227	CcSEcCtD
Adenosine—Chest pain—Gemcitabine—urinary bladder cancer	0.00018	0.00227	CcSEcCtD
Adenosine—ADK—Metabolism—UGT2B7—urinary bladder cancer	0.000178	0.00339	CbGpPWpGaD
Adenosine—Discomfort—Gemcitabine—urinary bladder cancer	0.000178	0.00224	CcSEcCtD
Adenosine—Chest pain—Fluorouracil—urinary bladder cancer	0.000177	0.00223	CcSEcCtD
Adenosine—Dysgeusia—Etoposide—urinary bladder cancer	0.000177	0.00223	CcSEcCtD
Adenosine—ADORA2A—Monoamine Transport—TNF—urinary bladder cancer	0.000176	0.00335	CbGpPWpGaD
Adenosine—Pain—Thiotepa—urinary bladder cancer	0.000175	0.00221	CcSEcCtD
Adenosine—Discomfort—Fluorouracil—urinary bladder cancer	0.000175	0.00221	CcSEcCtD
Adenosine—Back pain—Etoposide—urinary bladder cancer	0.000175	0.0022	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—EP300—urinary bladder cancer	0.000175	0.00332	CbGpPWpGaD
Adenosine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000173	0.00218	CcSEcCtD
Adenosine—Cardiac failure—Epirubicin—urinary bladder cancer	0.000172	0.00217	CcSEcCtD
Adenosine—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.000172	0.00216	CcSEcCtD
Adenosine—Convulsion—Cisplatin—urinary bladder cancer	0.000171	0.00215	CcSEcCtD
Adenosine—Mood swings—Methotrexate—urinary bladder cancer	0.00017	0.00215	CcSEcCtD
Adenosine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00017	0.00214	CcSEcCtD
Adenosine—Anxiety—Cisplatin—urinary bladder cancer	0.000167	0.00211	CcSEcCtD
Adenosine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000167	0.0021	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—FAS—urinary bladder cancer	0.000166	0.00316	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.000166	0.00315	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000166	0.00315	CbGpPWpGaD
Adenosine—Discomfort—Cisplatin—urinary bladder cancer	0.000166	0.00209	CcSEcCtD
Adenosine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000166	0.00209	CcSEcCtD
Adenosine—Affect lability—Epirubicin—urinary bladder cancer	0.000165	0.00209	CcSEcCtD
Adenosine—Urticaria—Thiotepa—urinary bladder cancer	0.000163	0.00206	CcSEcCtD
Adenosine—Hypotension—Gemcitabine—urinary bladder cancer	0.000161	0.00203	CcSEcCtD
Adenosine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000161	0.00203	CcSEcCtD
Adenosine—ADK—Metabolism—CYP4B1—urinary bladder cancer	0.000161	0.00305	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	0.00016	0.00305	CbGpPWpGaD
Adenosine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00016	0.00202	CcSEcCtD
Adenosine—ADA—p73 transcription factor network—MYC—urinary bladder cancer	0.00016	0.00304	CbGpPWpGaD
Adenosine—Cardiac failure—Doxorubicin—urinary bladder cancer	0.000159	0.00201	CcSEcCtD
Adenosine—Mood swings—Epirubicin—urinary bladder cancer	0.000159	0.00201	CcSEcCtD
Adenosine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000159	0.002	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.000159	0.002	CcSEcCtD
Adenosine—Hypotension—Fluorouracil—urinary bladder cancer	0.000159	0.002	CcSEcCtD
Adenosine—Cough—Etoposide—urinary bladder cancer	0.000158	0.00199	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000157	0.00198	CcSEcCtD
Adenosine—Tachycardia—Cisplatin—urinary bladder cancer	0.000157	0.00198	CcSEcCtD
Adenosine—Convulsion—Etoposide—urinary bladder cancer	0.000156	0.00197	CcSEcCtD
Adenosine—Hypertension—Etoposide—urinary bladder cancer	0.000156	0.00197	CcSEcCtD
Adenosine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000156	0.00196	CcSEcCtD
Adenosine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000155	0.00195	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000155	0.00195	CcSEcCtD
Adenosine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000154	0.00194	CcSEcCtD
Adenosine—Chest pain—Etoposide—urinary bladder cancer	0.000154	0.00194	CcSEcCtD
Adenosine—Somnolence—Gemcitabine—urinary bladder cancer	0.000153	0.00193	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—urinary bladder cancer	0.000153	0.00193	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—EP300—urinary bladder cancer	0.000153	0.0029	CbGpPWpGaD
Adenosine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000152	0.00192	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—MYC—urinary bladder cancer	0.000152	0.00289	CbGpPWpGaD
Adenosine—Discomfort—Etoposide—urinary bladder cancer	0.000152	0.00192	CcSEcCtD
Adenosine—ADK—Metabolism—SLC19A1—urinary bladder cancer	0.000152	0.00288	CbGpPWpGaD
Adenosine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000151	0.00191	CcSEcCtD
Adenosine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000151	0.00191	CcSEcCtD
Adenosine—Somnolence—Fluorouracil—urinary bladder cancer	0.000151	0.0019	CcSEcCtD
Adenosine—Hypotension—Cisplatin—urinary bladder cancer	0.00015	0.0019	CcSEcCtD
Adenosine—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000149	0.00188	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000148	0.00186	CcSEcCtD
Adenosine—ADK—Metabolism—PRSS3—urinary bladder cancer	0.000148	0.00281	CbGpPWpGaD
Adenosine—Pain—Gemcitabine—urinary bladder cancer	0.000148	0.00186	CcSEcCtD
Adenosine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000147	0.00186	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—urinary bladder cancer	0.000147	0.00186	CcSEcCtD
Adenosine—Asthenia—Thiotepa—urinary bladder cancer	0.000147	0.00186	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000147	0.00185	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000146	0.00278	CbGpPWpGaD
Adenosine—Pain—Fluorouracil—urinary bladder cancer	0.000145	0.00183	CcSEcCtD
Adenosine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000144	0.00182	CcSEcCtD
Adenosine—Tachycardia—Etoposide—urinary bladder cancer	0.000144	0.00181	CcSEcCtD
Adenosine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000143	0.00181	CcSEcCtD
Adenosine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000142	0.0018	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—KRAS—urinary bladder cancer	0.000141	0.00267	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTZ1—urinary bladder cancer	0.00014	0.00266	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000139	0.00265	CbGpPWpGaD
Adenosine—Drowsiness—Methotrexate—urinary bladder cancer	0.000138	0.00175	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000138	0.00262	CbGpPWpGaD
Adenosine—Hypotension—Etoposide—urinary bladder cancer	0.000138	0.00174	CcSEcCtD
Adenosine—Pain—Cisplatin—urinary bladder cancer	0.000138	0.00173	CcSEcCtD
Adenosine—Dizziness—Thiotepa—urinary bladder cancer	0.000136	0.00171	CcSEcCtD
Adenosine—Urticaria—Fluorouracil—urinary bladder cancer	0.000135	0.0017	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000134	0.00255	CbGpPWpGaD
Adenosine—Pollakiuria—Epirubicin—urinary bladder cancer	0.000134	0.00169	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—MYC—urinary bladder cancer	0.000133	0.00253	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000133	0.00252	CbGpPWpGaD
Adenosine—Sweating—Methotrexate—urinary bladder cancer	0.000133	0.00167	CcSEcCtD
Adenosine—ADA—Metabolism—NAT1—urinary bladder cancer	0.000133	0.00252	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTO2—urinary bladder cancer	0.000133	0.00252	CbGpPWpGaD
Adenosine—Paraesthesia—Etoposide—urinary bladder cancer	0.000132	0.00167	CcSEcCtD
Adenosine—Dyspnoea—Etoposide—urinary bladder cancer	0.000131	0.00166	CcSEcCtD
Adenosine—Somnolence—Etoposide—urinary bladder cancer	0.000131	0.00165	CcSEcCtD
Adenosine—Vomiting—Thiotepa—urinary bladder cancer	0.00013	0.00164	CcSEcCtD
Adenosine—Drowsiness—Epirubicin—urinary bladder cancer	0.00013	0.00163	CcSEcCtD
Adenosine—Rash—Thiotepa—urinary bladder cancer	0.000129	0.00163	CcSEcCtD
Adenosine—Dermatitis—Thiotepa—urinary bladder cancer	0.000129	0.00163	CcSEcCtD
Adenosine—Headache—Thiotepa—urinary bladder cancer	0.000129	0.00162	CcSEcCtD
Adenosine—Pain—Etoposide—urinary bladder cancer	0.000126	0.00159	CcSEcCtD
Adenosine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000125	0.00158	CcSEcCtD
Adenosine—Sweating—Epirubicin—urinary bladder cancer	0.000124	0.00157	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000124	0.00157	CcSEcCtD
Adenosine—Asthenia—Gemcitabine—urinary bladder cancer	0.000124	0.00156	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—FAS—urinary bladder cancer	0.000124	0.00235	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—KRAS—urinary bladder cancer	0.000123	0.00234	CbGpPWpGaD
Adenosine—Nausea—Thiotepa—urinary bladder cancer	0.000122	0.00154	CcSEcCtD
Adenosine—ADA—Metabolism—UGT2B7—urinary bladder cancer	0.000121	0.0023	CbGpPWpGaD
Adenosine—Drowsiness—Doxorubicin—urinary bladder cancer	0.00012	0.00151	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—HRAS—urinary bladder cancer	0.000119	0.00227	CbGpPWpGaD
Adenosine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000119	0.00149	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—urinary bladder cancer	0.000118	0.00149	CcSEcCtD
Adenosine—ADK—Metabolism—TYMP—urinary bladder cancer	0.000118	0.00225	CbGpPWpGaD
Adenosine—Urticaria—Etoposide—urinary bladder cancer	0.000117	0.00148	CcSEcCtD
Adenosine—Tinnitus—Methotrexate—urinary bladder cancer	0.000116	0.00146	CcSEcCtD
Adenosine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000116	0.00146	CcSEcCtD
Adenosine—Asthenia—Cisplatin—urinary bladder cancer	0.000115	0.00146	CcSEcCtD
Adenosine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000115	0.00145	CcSEcCtD
Adenosine—Sweating—Doxorubicin—urinary bladder cancer	0.000115	0.00145	CcSEcCtD
Adenosine—Dizziness—Fluorouracil—urinary bladder cancer	0.000112	0.00141	CcSEcCtD
Adenosine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000112	0.00141	CcSEcCtD
Adenosine—Vomiting—Gemcitabine—urinary bladder cancer	0.00011	0.00138	CcSEcCtD
Adenosine—Bradycardia—Doxorubicin—urinary bladder cancer	0.00011	0.00138	CcSEcCtD
Adenosine—ADA—Metabolism—CYP4B1—urinary bladder cancer	0.000109	0.00207	CbGpPWpGaD
Adenosine—Rash—Gemcitabine—urinary bladder cancer	0.000109	0.00137	CcSEcCtD
Adenosine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000109	0.00137	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000109	0.00207	CbGpPWpGaD
Adenosine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000109	0.00137	CcSEcCtD
Adenosine—Tinnitus—Epirubicin—urinary bladder cancer	0.000108	0.00137	CcSEcCtD
Adenosine—Headache—Gemcitabine—urinary bladder cancer	0.000108	0.00136	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000108	0.00136	CcSEcCtD
Adenosine—Flushing—Epirubicin—urinary bladder cancer	0.000108	0.00136	CcSEcCtD
Adenosine—Vomiting—Fluorouracil—urinary bladder cancer	0.000108	0.00136	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000108	0.00205	CbGpPWpGaD
Adenosine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000107	0.00135	CcSEcCtD
Adenosine—Rash—Fluorouracil—urinary bladder cancer	0.000107	0.00135	CcSEcCtD
Adenosine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000107	0.00135	CcSEcCtD
Adenosine—ADK—Metabolism—NAT2—urinary bladder cancer	0.000107	0.00203	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000106	0.00202	CbGpPWpGaD
Adenosine—Headache—Fluorouracil—urinary bladder cancer	0.000106	0.00134	CcSEcCtD
Adenosine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000106	0.00134	CcSEcCtD
Adenosine—Asthenia—Etoposide—urinary bladder cancer	0.000106	0.00133	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000105	0.00132	CcSEcCtD
Adenosine—Back pain—Methotrexate—urinary bladder cancer	0.000105	0.00132	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—HRAS—urinary bladder cancer	0.000105	0.00199	CbGpPWpGaD
Adenosine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000104	0.00131	CcSEcCtD
Adenosine—ADA—Metabolism—SLC19A1—urinary bladder cancer	0.000103	0.00196	CbGpPWpGaD
Adenosine—Nausea—Gemcitabine—urinary bladder cancer	0.000103	0.00129	CcSEcCtD
Adenosine—Vomiting—Cisplatin—urinary bladder cancer	0.000102	0.00129	CcSEcCtD
Adenosine—Vision blurred—Methotrexate—urinary bladder cancer	0.000102	0.00129	CcSEcCtD
Adenosine—Rash—Cisplatin—urinary bladder cancer	0.000101	0.00128	CcSEcCtD
Adenosine—Dermatitis—Cisplatin—urinary bladder cancer	0.000101	0.00128	CcSEcCtD
Adenosine—Nausea—Fluorouracil—urinary bladder cancer	0.000101	0.00127	CcSEcCtD
Adenosine—ADA—Metabolism—PRSS3—urinary bladder cancer	0.0001	0.00191	CbGpPWpGaD
Adenosine—Tinnitus—Doxorubicin—urinary bladder cancer	0.0001	0.00126	CcSEcCtD
Adenosine—Flushing—Doxorubicin—urinary bladder cancer	9.99e-05	0.00126	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—urinary bladder cancer	9.99e-05	0.00126	CcSEcCtD
Adenosine—Tension—Epirubicin—urinary bladder cancer	9.93e-05	0.00125	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—urinary bladder cancer	9.91e-05	0.00125	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—PPARG—urinary bladder cancer	9.88e-05	0.00188	CbGpPWpGaD
Adenosine—Nervousness—Epirubicin—urinary bladder cancer	9.83e-05	0.00124	CcSEcCtD
Adenosine—Back pain—Epirubicin—urinary bladder cancer	9.79e-05	0.00123	CcSEcCtD
Adenosine—Dizziness—Etoposide—urinary bladder cancer	9.75e-05	0.00123	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	9.7e-05	0.00122	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—urinary bladder cancer	9.61e-05	0.00121	CcSEcCtD
Adenosine—Nausea—Cisplatin—urinary bladder cancer	9.56e-05	0.0012	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—urinary bladder cancer	9.54e-05	0.0012	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—FAS—urinary bladder cancer	9.54e-05	0.00181	CbGpPWpGaD
Adenosine—Cough—Methotrexate—urinary bladder cancer	9.44e-05	0.00119	CcSEcCtD
Adenosine—Convulsion—Methotrexate—urinary bladder cancer	9.37e-05	0.00118	CcSEcCtD
Adenosine—Vomiting—Etoposide—urinary bladder cancer	9.37e-05	0.00118	CcSEcCtD
Adenosine—Agitation—Epirubicin—urinary bladder cancer	9.3e-05	0.00117	CcSEcCtD
Adenosine—Rash—Etoposide—urinary bladder cancer	9.29e-05	0.00117	CcSEcCtD
Adenosine—Dermatitis—Etoposide—urinary bladder cancer	9.28e-05	0.00117	CcSEcCtD
Adenosine—Headache—Etoposide—urinary bladder cancer	9.23e-05	0.00116	CcSEcCtD
Adenosine—ADK—Metabolism—RRM2—urinary bladder cancer	9.23e-05	0.00175	CbGpPWpGaD
Adenosine—Chest pain—Methotrexate—urinary bladder cancer	9.21e-05	0.00116	CcSEcCtD
Adenosine—Tension—Doxorubicin—urinary bladder cancer	9.19e-05	0.00116	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—urinary bladder cancer	9.17e-05	0.00116	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—PTEN—urinary bladder cancer	9.11e-05	0.00173	CbGpPWpGaD
Adenosine—Discomfort—Methotrexate—urinary bladder cancer	9.1e-05	0.00115	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—urinary bladder cancer	9.1e-05	0.00115	CcSEcCtD
Adenosine—Syncope—Epirubicin—urinary bladder cancer	9.08e-05	0.00114	CcSEcCtD
Adenosine—Back pain—Doxorubicin—urinary bladder cancer	9.06e-05	0.00114	CcSEcCtD
Adenosine—Palpitations—Epirubicin—urinary bladder cancer	8.95e-05	0.00113	CcSEcCtD
Adenosine—Loss of consciousness—Epirubicin—urinary bladder cancer	8.9e-05	0.00112	CcSEcCtD
Adenosine—Cough—Epirubicin—urinary bladder cancer	8.83e-05	0.00111	CcSEcCtD
Adenosine—Anaphylactic shock—Methotrexate—urinary bladder cancer	8.83e-05	0.00111	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—urinary bladder cancer	8.83e-05	0.00111	CcSEcCtD
Adenosine—Convulsion—Epirubicin—urinary bladder cancer	8.77e-05	0.00111	CcSEcCtD
Adenosine—Nausea—Etoposide—urinary bladder cancer	8.75e-05	0.0011	CcSEcCtD
Adenosine—Hypertension—Epirubicin—urinary bladder cancer	8.74e-05	0.0011	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—EP300—urinary bladder cancer	8.69e-05	0.00165	CbGpPWpGaD
Adenosine—Chest pain—Epirubicin—urinary bladder cancer	8.62e-05	0.00109	CcSEcCtD
Adenosine—Agitation—Doxorubicin—urinary bladder cancer	8.61e-05	0.00109	CcSEcCtD
Adenosine—Anxiety—Epirubicin—urinary bladder cancer	8.59e-05	0.00108	CcSEcCtD
Adenosine—ADK—Metabolism—HPGDS—urinary bladder cancer	8.54e-05	0.00162	CbGpPWpGaD
Adenosine—ADK—Metabolism—ENO2—urinary bladder cancer	8.54e-05	0.00162	CbGpPWpGaD
Adenosine—Hyperhidrosis—Methotrexate—urinary bladder cancer	8.53e-05	0.00108	CcSEcCtD
Adenosine—Discomfort—Epirubicin—urinary bladder cancer	8.51e-05	0.00107	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR3—urinary bladder cancer	8.44e-05	0.0016	CbGpPWpGaD
Adenosine—Dry mouth—Epirubicin—urinary bladder cancer	8.43e-05	0.00106	CcSEcCtD
Adenosine—Syncope—Doxorubicin—urinary bladder cancer	8.4e-05	0.00106	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—CDK4—urinary bladder cancer	8.39e-05	0.00159	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTT1—urinary bladder cancer	8.29e-05	0.00157	CbGpPWpGaD
Adenosine—Palpitations—Doxorubicin—urinary bladder cancer	8.28e-05	0.00104	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—urinary bladder cancer	8.26e-05	0.00104	CcSEcCtD
Adenosine—Hypotension—Methotrexate—urinary bladder cancer	8.25e-05	0.00104	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—urinary bladder cancer	8.23e-05	0.00104	CcSEcCtD
Adenosine—Cough—Doxorubicin—urinary bladder cancer	8.17e-05	0.00103	CcSEcCtD
Adenosine—Shock—Epirubicin—urinary bladder cancer	8.13e-05	0.00102	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—urinary bladder cancer	8.12e-05	0.00102	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—urinary bladder cancer	8.09e-05	0.00102	CcSEcCtD
Adenosine—Tachycardia—Epirubicin—urinary bladder cancer	8.06e-05	0.00102	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	8.04e-05	0.00101	CcSEcCtD
Adenosine—ADA—Metabolism—TYMP—urinary bladder cancer	8.03e-05	0.00153	CbGpPWpGaD
Adenosine—Hyperhidrosis—Epirubicin—urinary bladder cancer	7.99e-05	0.00101	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—urinary bladder cancer	7.97e-05	0.00101	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—urinary bladder cancer	7.95e-05	0.001	CcSEcCtD
Adenosine—Paraesthesia—Methotrexate—urinary bladder cancer	7.93e-05	0.000999	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—urinary bladder cancer	7.88e-05	0.000993	CcSEcCtD
Adenosine—Dyspnoea—Methotrexate—urinary bladder cancer	7.87e-05	0.000992	CcSEcCtD
Adenosine—Somnolence—Methotrexate—urinary bladder cancer	7.85e-05	0.000989	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—urinary bladder cancer	7.8e-05	0.000983	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.76e-05	0.00147	CbGpPWpGaD
Adenosine—Hypotension—Epirubicin—urinary bladder cancer	7.72e-05	0.000973	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	7.64e-05	0.000964	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—PPARG—urinary bladder cancer	7.62e-05	0.00145	CbGpPWpGaD
Adenosine—Pain—Methotrexate—urinary bladder cancer	7.55e-05	0.000952	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	7.53e-05	0.000949	CcSEcCtD
Adenosine—Shock—Doxorubicin—urinary bladder cancer	7.52e-05	0.000948	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—urinary bladder cancer	7.46e-05	0.000941	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—urinary bladder cancer	7.42e-05	0.000935	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	7.39e-05	0.000932	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—urinary bladder cancer	7.37e-05	0.000929	CcSEcCtD
Adenosine—Somnolence—Epirubicin—urinary bladder cancer	7.34e-05	0.000926	CcSEcCtD
Adenosine—ADA—Metabolism—NAT2—urinary bladder cancer	7.27e-05	0.00138	CbGpPWpGaD
Adenosine—Hypotension—Doxorubicin—urinary bladder cancer	7.14e-05	0.000901	CcSEcCtD
Adenosine—Pain—Epirubicin—urinary bladder cancer	7.06e-05	0.000891	CcSEcCtD
Adenosine—ADORA2B—Signaling Pathways—HDAC4—urinary bladder cancer	7.01e-05	0.00133	CbGpPWpGaD
Adenosine—Urticaria—Methotrexate—urinary bladder cancer	7.01e-05	0.000884	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	6.96e-05	0.000878	CcSEcCtD
Adenosine—ADK—Metabolism—NQO1—urinary bladder cancer	6.89e-05	0.00131	CbGpPWpGaD
Adenosine—Paraesthesia—Doxorubicin—urinary bladder cancer	6.86e-05	0.000865	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—urinary bladder cancer	6.81e-05	0.000859	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—urinary bladder cancer	6.8e-05	0.000857	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—PTEN—urinary bladder cancer	6.77e-05	0.00129	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—CXCL8—urinary bladder cancer	6.65e-05	0.00126	CbGpPWpGaD
Adenosine—Urticaria—Epirubicin—urinary bladder cancer	6.56e-05	0.000827	CcSEcCtD
Adenosine—Pain—Doxorubicin—urinary bladder cancer	6.54e-05	0.000824	CcSEcCtD
Adenosine—Hypersensitivity—Methotrexate—urinary bladder cancer	6.5e-05	0.00082	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—RHOA—urinary bladder cancer	6.5e-05	0.00123	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—FGFR3—urinary bladder cancer	6.49e-05	0.00123	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—EP300—urinary bladder cancer	6.46e-05	0.00123	CbGpPWpGaD
Adenosine—Asthenia—Methotrexate—urinary bladder cancer	6.33e-05	0.000799	CcSEcCtD
Adenosine—ADA—Metabolism—RRM2—urinary bladder cancer	6.27e-05	0.00119	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	6.22e-05	0.00118	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—TP53—urinary bladder cancer	6.22e-05	0.00118	CbGpPWpGaD
Adenosine—Hypersensitivity—Epirubicin—urinary bladder cancer	6.09e-05	0.000767	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—urinary bladder cancer	6.07e-05	0.000766	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—urinary bladder cancer	6.01e-05	0.00114	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HDAC4—urinary bladder cancer	5.96e-05	0.00113	CbGpPWpGaD
Adenosine—Asthenia—Epirubicin—urinary bladder cancer	5.93e-05	0.000747	CcSEcCtD
Adenosine—ADORA2B—Signaling Pathways—GLI1—urinary bladder cancer	5.88e-05	0.00112	CbGpPWpGaD
Adenosine—Dizziness—Methotrexate—urinary bladder cancer	5.84e-05	0.000736	CcSEcCtD
Adenosine—ADA—Metabolism—HPGDS—urinary bladder cancer	5.81e-05	0.0011	CbGpPWpGaD
Adenosine—ADA—Metabolism—ENO2—urinary bladder cancer	5.81e-05	0.0011	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTP1—urinary bladder cancer	5.74e-05	0.00109	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—IGF1—urinary bladder cancer	5.68e-05	0.00108	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTT1—urinary bladder cancer	5.63e-05	0.00107	CbGpPWpGaD
Adenosine—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.63e-05	0.00071	CcSEcCtD
Adenosine—Vomiting—Methotrexate—urinary bladder cancer	5.61e-05	0.000708	CcSEcCtD
Adenosine—Rash—Methotrexate—urinary bladder cancer	5.57e-05	0.000702	CcSEcCtD
Adenosine—Dermatitis—Methotrexate—urinary bladder cancer	5.56e-05	0.000701	CcSEcCtD
Adenosine—Headache—Methotrexate—urinary bladder cancer	5.53e-05	0.000697	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—urinary bladder cancer	5.48e-05	0.000691	CcSEcCtD
Adenosine—Dizziness—Epirubicin—urinary bladder cancer	5.46e-05	0.000689	CcSEcCtD
Adenosine—ADK—Metabolism—TYMS—urinary bladder cancer	5.34e-05	0.00101	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	5.29e-05	0.001	CbGpPWpGaD
Adenosine—ADK—Metabolism—NCOR1—urinary bladder cancer	5.28e-05	0.001	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTM1—urinary bladder cancer	5.28e-05	0.001	CbGpPWpGaD
Adenosine—Vomiting—Epirubicin—urinary bladder cancer	5.25e-05	0.000662	CcSEcCtD
Adenosine—Nausea—Methotrexate—urinary bladder cancer	5.24e-05	0.000661	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—PTEN—urinary bladder cancer	5.23e-05	0.000994	CbGpPWpGaD
Adenosine—Rash—Epirubicin—urinary bladder cancer	5.21e-05	0.000657	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—urinary bladder cancer	5.2e-05	0.000656	CcSEcCtD
Adenosine—Headache—Epirubicin—urinary bladder cancer	5.18e-05	0.000653	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—urinary bladder cancer	5.14e-05	0.000977	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—urinary bladder cancer	5.13e-05	0.000975	CbGpPWpGaD
Adenosine—ADK—Metabolism—GPX1—urinary bladder cancer	5.06e-05	0.000961	CbGpPWpGaD
Adenosine—Dizziness—Doxorubicin—urinary bladder cancer	5.05e-05	0.000637	CcSEcCtD
Adenosine—ADORA2A—Signaling by NGF—RHOA—urinary bladder cancer	5e-05	0.00095	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GLI1—urinary bladder cancer	5e-05	0.00095	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—EP300—urinary bladder cancer	4.99e-05	0.000948	CbGpPWpGaD
Adenosine—ADK—Metabolism—ERCC2—urinary bladder cancer	4.96e-05	0.000943	CbGpPWpGaD
Adenosine—Nausea—Epirubicin—urinary bladder cancer	4.91e-05	0.000619	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—urinary bladder cancer	4.86e-05	0.000613	CcSEcCtD
Adenosine—Rash—Doxorubicin—urinary bladder cancer	4.82e-05	0.000608	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—urinary bladder cancer	4.82e-05	0.000607	CcSEcCtD
Adenosine—Headache—Doxorubicin—urinary bladder cancer	4.79e-05	0.000604	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—SRC—urinary bladder cancer	4.76e-05	0.000904	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CXCL8—urinary bladder cancer	4.73e-05	0.0009	CbGpPWpGaD
Adenosine—ADA—Metabolism—NQO1—urinary bladder cancer	4.68e-05	0.00089	CbGpPWpGaD
Adenosine—ADK—Metabolism—MTHFR—urinary bladder cancer	4.67e-05	0.000887	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—ERBB2—urinary bladder cancer	4.63e-05	0.000879	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TP53—urinary bladder cancer	4.62e-05	0.000879	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HDAC4—urinary bladder cancer	4.6e-05	0.000875	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CXCL8—urinary bladder cancer	4.57e-05	0.000867	CbGpPWpGaD
Adenosine—Nausea—Doxorubicin—urinary bladder cancer	4.54e-05	0.000572	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—urinary bladder cancer	4.17e-05	0.000792	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	4.08e-05	0.000776	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RBX1—urinary bladder cancer	4.03e-05	0.000765	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CXCL8—urinary bladder cancer	4.03e-05	0.000765	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CDKN1A—urinary bladder cancer	3.95e-05	0.000751	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PTEN—urinary bladder cancer	3.94e-05	0.00075	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—urinary bladder cancer	3.94e-05	0.000748	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTP1—urinary bladder cancer	3.9e-05	0.000742	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GLI1—urinary bladder cancer	3.86e-05	0.000733	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TSC1—urinary bladder cancer	3.79e-05	0.00072	CbGpPWpGaD
Adenosine—ADK—Metabolism—PPARG—urinary bladder cancer	3.78e-05	0.000719	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—SRC—urinary bladder cancer	3.66e-05	0.000695	CbGpPWpGaD
Adenosine—ADK—Metabolism—CREBBP—urinary bladder cancer	3.63e-05	0.000691	CbGpPWpGaD
Adenosine—ADA—Metabolism—TYMS—urinary bladder cancer	3.63e-05	0.00069	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JAG1—urinary bladder cancer	3.61e-05	0.000685	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTM1—urinary bladder cancer	3.59e-05	0.000682	CbGpPWpGaD
Adenosine—ADA—Metabolism—NCOR1—urinary bladder cancer	3.59e-05	0.000682	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—urinary bladder cancer	3.57e-05	0.000678	CbGpPWpGaD
Adenosine—ADA—Metabolism—GPX1—urinary bladder cancer	3.44e-05	0.000653	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RBX1—urinary bladder cancer	3.42e-05	0.000651	CbGpPWpGaD
Adenosine—ADA—Metabolism—ERCC2—urinary bladder cancer	3.37e-05	0.000641	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—urinary bladder cancer	3.35e-05	0.000636	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TSC1—urinary bladder cancer	3.22e-05	0.000612	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—EGFR—urinary bladder cancer	3.21e-05	0.000609	CbGpPWpGaD
Adenosine—ADA—Metabolism—MTHFR—urinary bladder cancer	3.17e-05	0.000603	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL8—urinary bladder cancer	3.11e-05	0.000591	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JAG1—urinary bladder cancer	3.07e-05	0.000583	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—RHOA—urinary bladder cancer	3.05e-05	0.000579	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KRAS—urinary bladder cancer	3.03e-05	0.000576	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS2—urinary bladder cancer	2.98e-05	0.000566	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—S100B—urinary bladder cancer	2.92e-05	0.000555	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—RHOA—urinary bladder cancer	2.77e-05	0.000526	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.68e-05	0.000508	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RBX1—urinary bladder cancer	2.64e-05	0.000502	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NCOR1—urinary bladder cancer	2.63e-05	0.000499	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTEN—urinary bladder cancer	2.6e-05	0.000493	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—RHOA—urinary bladder cancer	2.59e-05	0.000492	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—HRAS—urinary bladder cancer	2.57e-05	0.000489	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPARG—urinary bladder cancer	2.57e-05	0.000489	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—IL2—urinary bladder cancer	2.56e-05	0.000486	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TSC1—urinary bladder cancer	2.49e-05	0.000472	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—S100B—urinary bladder cancer	2.48e-05	0.000472	CbGpPWpGaD
Adenosine—ADK—Metabolism—EP300—urinary bladder cancer	2.48e-05	0.00047	CbGpPWpGaD
Adenosine—ADA—Metabolism—CREBBP—urinary bladder cancer	2.47e-05	0.000469	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL8—urinary bladder cancer	2.43e-05	0.000462	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JAG1—urinary bladder cancer	2.37e-05	0.00045	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—RHOA—urinary bladder cancer	2.35e-05	0.000447	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL2—urinary bladder cancer	2.32e-05	0.000441	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TERT—urinary bladder cancer	2.31e-05	0.00044	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.27e-05	0.000432	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NCOR1—urinary bladder cancer	2.23e-05	0.000424	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL2—urinary bladder cancer	2.17e-05	0.000413	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGFR3—urinary bladder cancer	2.12e-05	0.000403	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—urinary bladder cancer	2.07e-05	0.000393	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ESR1—urinary bladder cancer	2.06e-05	0.000392	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—urinary bladder cancer	2.02e-05	0.000384	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—RHOA—urinary bladder cancer	2e-05	0.00038	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL2—urinary bladder cancer	1.97e-05	0.000375	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TERT—urinary bladder cancer	1.97e-05	0.000374	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—S100B—urinary bladder cancer	1.92e-05	0.000364	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—RHOA—urinary bladder cancer	1.82e-05	0.000345	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CREBBP—urinary bladder cancer	1.81e-05	0.000343	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGFR3—urinary bladder cancer	1.81e-05	0.000343	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1—urinary bladder cancer	1.78e-05	0.000339	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—urinary bladder cancer	1.78e-05	0.000337	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTEN—urinary bladder cancer	1.76e-05	0.000335	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.76e-05	0.000334	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ESR1—urinary bladder cancer	1.75e-05	0.000333	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NCOR1—urinary bladder cancer	1.72e-05	0.000327	CbGpPWpGaD
Adenosine—ADA—Metabolism—EP300—urinary bladder cancer	1.68e-05	0.00032	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL2—urinary bladder cancer	1.68e-05	0.000319	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—KRAS—urinary bladder cancer	1.68e-05	0.000319	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RHOA—urinary bladder cancer	1.63e-05	0.000311	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—urinary bladder cancer	1.6e-05	0.000303	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CREBBP—urinary bladder cancer	1.54e-05	0.000292	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL2—urinary bladder cancer	1.52e-05	0.00029	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TERT—urinary bladder cancer	1.52e-05	0.000289	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1—urinary bladder cancer	1.52e-05	0.000288	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—urinary bladder cancer	1.51e-05	0.000288	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—urinary bladder cancer	1.51e-05	0.000287	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—urinary bladder cancer	1.44e-05	0.000273	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—KRAS—urinary bladder cancer	1.43e-05	0.000271	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HRAS—urinary bladder cancer	1.43e-05	0.000271	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGFR3—urinary bladder cancer	1.39e-05	0.000265	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RHOA—urinary bladder cancer	1.39e-05	0.000264	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL2—urinary bladder cancer	1.37e-05	0.000261	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ESR1—urinary bladder cancer	1.35e-05	0.000257	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCND1—urinary bladder cancer	1.34e-05	0.000254	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—urinary bladder cancer	1.3e-05	0.000247	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	1.29e-05	0.000246	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTEN—urinary bladder cancer	1.29e-05	0.000245	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—urinary bladder cancer	1.29e-05	0.000245	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EP300—urinary bladder cancer	1.23e-05	0.000234	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—urinary bladder cancer	1.22e-05	0.000232	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HRAS—urinary bladder cancer	1.21e-05	0.00023	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SRC—urinary bladder cancer	1.2e-05	0.000227	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CREBBP—urinary bladder cancer	1.19e-05	0.000225	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1—urinary bladder cancer	1.17e-05	0.000223	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL2—urinary bladder cancer	1.17e-05	0.000222	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—urinary bladder cancer	1.17e-05	0.000222	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCND1—urinary bladder cancer	1.14e-05	0.000216	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—urinary bladder cancer	1.1e-05	0.00021	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KRAS—urinary bladder cancer	1.1e-05	0.000209	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.1e-05	0.000209	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTEN—urinary bladder cancer	1.1e-05	0.000209	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RHOA—urinary bladder cancer	1.07e-05	0.000204	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—urinary bladder cancer	1.07e-05	0.000204	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—urinary bladder cancer	1.05e-05	0.000199	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EP300—urinary bladder cancer	1.05e-05	0.000199	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SRC—urinary bladder cancer	1.02e-05	0.000193	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—urinary bladder cancer	9.94e-06	0.000189	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KRAS—urinary bladder cancer	9.91e-06	0.000188	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—urinary bladder cancer	9.42e-06	0.000179	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HRAS—urinary bladder cancer	9.36e-06	0.000178	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—urinary bladder cancer	9.12e-06	0.000173	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL2—urinary bladder cancer	9e-06	0.000171	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—urinary bladder cancer	8.92e-06	0.000169	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—urinary bladder cancer	8.81e-06	0.000167	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCND1—urinary bladder cancer	8.78e-06	0.000167	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—urinary bladder cancer	8.52e-06	0.000162	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	8.49e-06	0.000161	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTEN—urinary bladder cancer	8.47e-06	0.000161	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KRAS—urinary bladder cancer	8.43e-06	0.00016	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HRAS—urinary bladder cancer	8.42e-06	0.00016	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EP300—urinary bladder cancer	8.08e-06	0.000154	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SRC—urinary bladder cancer	7.86e-06	0.000149	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—urinary bladder cancer	7.49e-06	0.000142	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HRAS—urinary bladder cancer	7.16e-06	0.000136	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—urinary bladder cancer	7.04e-06	0.000134	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—urinary bladder cancer	6.89e-06	0.000131	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KRAS—urinary bladder cancer	6.51e-06	0.000124	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—urinary bladder cancer	5.78e-06	0.00011	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HRAS—urinary bladder cancer	5.53e-06	0.000105	CbGpPWpGaD
